Cargando…

Enzyme replacement therapies: what is the best option?

Despite many beneficial outcomes of the conventional enzyme replacement therapy (ERT), several limitations such as the high-cost of the treatment and various inadvertent side effects including the occurrence of an immunological response against the infused enzyme and development of resistance to enz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safary, Azam, Akbarzadeh Khiavi, Mostafa, Mousavi, Rahimeh, Barar, Jaleh, Rafi, Mohammad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128977/ https://www.ncbi.nlm.nih.gov/pubmed/30211074 http://dx.doi.org/10.15171/bi.2018.17

Ejemplares similares

SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system
por: Safary, Azam, et al.
Publicado: (2023)

PEGylated gold nanoparticles-ribonuclease induced oxidative stress and apoptosis in colorectal cancer cells
por: Akbarzadeh Khiavi, Mostafa, et al.
Publicado: (2020)

Therapeutic impacts of enzyme-responsive smart nanobiosystems
por: Fathi, Marziyeh, et al.
Publicado: (2020)

Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates
por: Akbarzadeh Khiavi, Mostafa, et al.
Publicado: (2019)

Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection
por: Akbarzadeh-Khiavi, Mostafa, et al.
Publicado: (2021)

BioImpacts: An emerging global journal
por: Ilghami, Roghaiyeh, et al.
Publicado: (2020)

Micronutrient therapy and effective immune response: a promising approach for management of COVID-19
por: Lotfi, Fariba, et al.
Publicado: (2021)

Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19
por: Lotfi, Fariba, et al.
Publicado: (2022)

Exosomes as versatile nanoscaled biocompartments in cancer therapy and/or resistance
por: Rahbar Saadat, Yalda, et al.
Publicado: (2022)

Bioimpacts of nanoparticle size: why it matters?
por: Barar, Jaleh
Publicado: (2015)

COVID-19 clinical implications: the significance of nanomedicine
por: Barar, Jaleh
Publicado: (2020)

Blood-brain barrier transport machineries and targeted therapy of brain diseases
por: Barar, Jaleh, et al.
Publicado: (2016)

Aptamedicine: a new treatment modality in personalized cancer therapy
por: Vandghanooni, Somayeh, et al.
Publicado: (2019)

Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignancies
por: Barar, Jaleh, et al.
Publicado: (2015)

Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
por: Hashemzadeh, Nastran, et al.
Publicado: (2019)

Hydrogels for ocular drug delivery and tissue engineering
por: Fathi, Marzieh, et al.
Publicado: (2015)

Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer
por: Barar, Jaleh, et al.
Publicado: (2014)

Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors
por: Fathi, Marziyeh, et al.
Publicado: (2017)

Dry January: The best option for public health?
por: eClinical Medicine
Publicado: (2022)

Enzyme replacement therapy in India: Lessons and insights
por: Muranjan, M, et al.
Publicado: (2018)

What is the best way to support patients undergoing radiation therapy?
por: Halkett, Georgia, et al.
Publicado: (2015)

What Is the Best High Potency
Publicado: (1893)

Best treatment option for clinical stage I seminoma patients
por: Tüzel, Emre
Publicado: (2016)

The best option for complicated type B dissection with arch involved
por: Shu, Chang, et al.
Publicado: (2021)

Cellular models for human cardiomyopathy: What is the best option?
por: Jimenez-Tellez, Nerea, et al.
Publicado: (2019)

Inferior turbinectomy: what is the best technique?()
por: Roithmann, Renato
Publicado: (2017)

Transcatheter pulmonary valve replacement: an option for some but not for all
por: Bavishi, Chirag, et al.
Publicado: (2020)

Opioid Dependent and Pregnant: What Are the Best Options for Mothers and Neonates?
por: Unger, Annemarie, et al.
Publicado: (2012)

Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines
por: Omidi, Yadollah, et al.
Publicado: (2014)

Wanted: The Best Second Option to Treat Macrolide-Unresponsive Mycoplasmal Pneumonia in Children
por: Jo, Dae Sun
Publicado: (2018)

Physical Activity and Health: What Is the Best Dose?
por: Kaminsky, Leonard A., et al.
Publicado: (2014)

Disentangling what works best for whom in comorbidity
por: Glozier, Nick, et al.
Publicado: (2022)

Revisiting endovascular treatment in below-the-knee disease. Are drug-eluting stents the best option?
por: Spiliopoulos, Stavros, et al.
Publicado: (2018)

Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
por: Kim, Hyo-Cheol
Publicado: (2023)

What is Currently the Best for Adenocarcinoma without Driver Mutation?
por: Park, Cheol-Kyu, et al.
Publicado: (2018)

What is the best way to care for frail older adults?
por: Madden, Kenneth M.
Publicado: (2013)

The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)

Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options?
por: Buades, Juan M., et al.
Publicado: (2021)

Considerations for evaluating the effectiveness and long-term outcome of enzyme replacement therapy in Pompe disease
por: Cheon, Chong Kun
Publicado: (2019)

Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells
por: Barar, Jaleh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o9av873egj08bftjf3ft0qc463